Arrowhead Pharmaceuticals, Inc.

NEW YORK STATE COMMON RETIREMENT FUND ARWR

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

41,879

Value ($000)

2,780

Weight

0.0%

2019 Q4 - 2025 Q4 (25 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	2,780	0.0%	41,879	12/31/2025
2025 Q3	11/3/2025	1,282	0.0%	37,179	9/30/2025
2025 Q2	10/8/2025	584	0.0%	36,979	6/30/2025
2025 Q1	10/8/2025	471	0.0%	36,979	3/31/2025
2024 Q4	10/8/2025	695	0.0%	36,979	12/31/2024
2024 Q3	10/8/2025	716	0.0%	36,979	9/30/2024
2024 Q2	10/8/2025	1,328	0.0%	51,079	6/30/2024
2024 Q1	10/8/2025	1,321	0.0%	46,200	3/31/2024
2023 Q4	10/8/2025	1,242	0.0%	40,600	12/31/2023
2023 Q3	10/8/2025	1,152	0.0%	42,866	9/30/2023
2023 Q2	10/8/2025	1,493	0.0%	41,867	6/30/2023
2023 Q1	10/8/2025	1,351	0.0%	53,200	3/31/2023
2022 Q4	10/8/2025	14,286	0.0%	352,222	12/31/2022
2022 Q3	11/8/2022	11,535	0.0%	349,022	9/30/2022
2022 Q2	8/4/2022	12,290	0.0%	349,041	6/30/2022
2022 Q1	7/1/2022	16,024	0.0%	348,422	3/31/2022
2021 Q4	2/2/2022	23,158	0.0%	349,295	12/31/2021
2021 Q3	11/2/2021	21,719	0.0%	347,892	9/30/2021
2021 Q2	8/2/2021	31,167	0.0%	376,325	6/30/2021
2021 Q1	5/11/2021	24,324	0.0%	366,822	3/31/2021
2020 Q4	2/8/2021	28,881	0.0%	376,392	12/31/2020
2020 Q3	11/5/2020	15,791	0.0%	366,722	9/30/2020
2020 Q2	8/7/2020	15,942	0.0%	369,122	6/30/2020
2020 Q1	5/6/2020	10,375	0.0%	360,622	3/31/2020
2019 Q4	2/5/2020	22,874	0.0%	360,622	12/31/2019